1/5
04:10 pm
kala
KALA BIO Settles Approximately $10.6 million of Debt
Medium
Report
KALA BIO Settles Approximately $10.6 million of Debt
12/5
02:36 pm
kala
KALA BIO Announces Closing of $10 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules
Low
Report
KALA BIO Announces Closing of $10 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules
12/4
10:45 am
kala
KALA BIO Announces $10 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules
High
Report
KALA BIO Announces $10 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules
12/3
04:31 pm
kala
KALA BIO (NASDAQ:KALA) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
KALA BIO (NASDAQ:KALA) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
12/1
07:00 am
kala
KALA BIO Enters Into $6 Million Securities Purchase Agreement with Investor David E. Lazar
High
Report
KALA BIO Enters Into $6 Million Securities Purchase Agreement with Investor David E. Lazar
11/27
02:49 pm
kala
KALA BIO (NASDAQ:KALA) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
Medium
Report
KALA BIO (NASDAQ:KALA) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
11/21
02:02 pm
kala
KALA BIO (NASDAQ:KALA) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
KALA BIO (NASDAQ:KALA) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.